Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Autoimmune
Cancer
Cardiovascular
COVID-19
Health Topics
Infectious
Lung Adenocarcinoma
Upcoming lung cancer molecular testing guidelines address 7 questions
By
Liz Carey
Revised guideline addresses next-generation sequencing and expanded biomarker testing.
August 28, 2024
Universal Diagnostics touts blood-based lung cancer test
By
LabPulse.com staff writers
Presented at the International Association for the Study of Lung Cancer (IASLC) 2020 World Conference, the test uses methylation status measurement of the tumor-derived portion from cell-free DNA (cfDNA) in plasma for patient classification. Researchers examined plasma samples of 37 lung cancer patients and 71 asymptomatic age, gender, and smoking-history matching controls.
January 28, 2021
Google reports pathology AI helps predict survival in cancer patients
By
Emily Hayes
The deep-learning system was developed and tested using histopathology slides for patients with 10 cancer types -- including bladder cancer, invasive breast cancer, and head and neck squamous cell carcinoma -- drawing from publicly available data from the Cancer Genome Atlas (TCGA) program.
June 17, 2020
Liquid biopsy results help TARGET cancer treatments in U.K. study
By
Emily Hayes
In an ideal world, all cancer patients would get a personalized treatment regimen based on the molecular profile of their particular tumor. But tissue biopsies are invasive, and results may become outdated over time as cancers evolve.
April 22, 2019
Page 1 of 1